Conference icon

Conference

Ccx282-B, an orally active inhibitor of chemokine receptor Ccr9, shows anti-inflammatory and clinical activity in the treatment of Crohn's disease

Publication status:
Published

Actions


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Experimental Medicine Division, Clinical Medicine
Ungashe, S More by this author
Expand authors...
Volume:
132
Issue:
4
Pages:
A157-A157
Publication date:
2007-04-05
ISSN:
0016-5085
URN:
uuid:37f13f4e-8a9b-4ad1-8f4d-cc5bad788a48
Source identifiers:
66738
Local pid:
pubs:66738

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP